New drug combo shows promise for tough lung cancer
NCT ID NCT03836066
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a combination of two drugs, atezolizumab and bevacizumab, as the first treatment for people with advanced non-squamous lung cancer that has a high number of genetic mutations. The goal was to see if this drug pair could slow down cancer growth. The trial enrolled 41 participants and measured how long they lived without their cancer getting worse.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Complejo Hospitalario Universitario A Coruña
A Coruña, La Coruña, 15006, Spain
-
Complejo Hospitalario de Jaén
Jaén, Jaén, 23007, Spain
-
Complejo Hospitalario de Toledo
Toledo, Toledo, 45004, Spain
-
Complexo Hospitalario Universitario de Vigo
Vigo, Pontevedra, 36036, Spain
-
Consorci Sanitari de Terrassa
Terrassa, Barcelona, 08022, Spain
-
Consorcio Hospitalario Provincial de Castelló
Castelló, Castelló, 12004, Spain
-
Hospital Clínic de Barcelona
Barcelona, Barcelona, 08036, Spain
-
Hospital Clínico San Carlos
Madrid, Madrid, 28040, Spain
-
Hospital Clínico Universitario de Santiago
Santiago de Compostela, A Coruña, 15706, Spain
-
Hospital Clínico Universitario de Valencia
Valencia, Valencia, 46010, Spain
-
Hospital Clínico Universitario de Valladolid
Valladolid, Valladolid, 47003, Spain
-
Hospital General Universitario de Elche
Elche, Alicante, 03203, Spain
-
Hospital General Universitario de Málaga
Málaga, Málaga, 29010, Spain
-
Hospital General de Alicante
Alicante, Alicante, 03010, Spain
-
Hospital General de Valencia
Valencia, Valencia, 46014, Spain
-
Hospital La Princesa
Madrid, Madrid, 28006, Spain
-
Hospital Puerta de Hierro
Majadahonda, Madrid, 28222, Spain
-
Hospital Universitari i Politécnic La Fe
Valencia, Valencia, 46009, Spain
-
Hospital Universitario Fundación Jiménez Díaz
Madrid, Madrid, 28040, Spain
-
Hospital Universitario Lucus Augusti
Lugo, Lugo, 27003, Spain
-
Hospital Universitario Reina Sofía
Córdoba, Córdoba, 14004, Spain
-
Hospital Universitario Son Espases
Palma de Mallorca, Mallorca, 07120, Spain
-
Hospital Universitario Son Llàtzer
Palma de Mallorca, Mallorca, 07198, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, Barcelona, 08041, Spain
-
ICO Badalona
Badalona, Barcelona, 08916, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?